{
  "experiment_id": "c40656ac476ccc7d758b86f6fd3d97ac",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
  "system_instructions": "_No response_",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-11-15T04:13:10.727789",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow down the broad terms to more specific ones as per the Target Schema provided.\n\n1. **Diagnosis**: The input is \"Neurofibromatosis\". The Target Schema provides several specific types related to Neurofibromatosis, such as \"Neurofibromatosis type 1\". Since \"Neurofibromatosis\" is most commonly associated with \"Neurofibromatosis type 1\" and it's the most specific term available in the schema related to Neurofibromatosis, we will use \"Neurofibromatosis type 1\".\n\n2. **Assay**: The input is \"DNA sequencing\". The Target Schema lists various sequencing and genetic analysis techniques. \"DNA sequencing\" is a broad term that can be narrowed down to more specific techniques. The closest and most appropriate term from the schema is \"Sanger sequencing\" or other next-generation sequencing techniques like \"whole exome sequencing\" or \"whole genome sequencing\". However, without more specific information on the type of DNA sequencing, we'll choose \"Sanger sequencing\" as it's a specific and commonly used method.\n\n3. **TumorType**: The input is \"Neurofibroma\". The Target Schema provides several specific types of Neurofibroma. \"Neurofibroma\" is a broad term that can be specified into types like \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", etc. Since the exact type of Neurofibroma isn't specified, we'll choose \"Neurofibroma\" as it is listed in the schema, assuming it's about the general category.\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction adheres to the Target Schema's controlled terminology, ensuring that the values used are exact and specific.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2304,
            "outputTokens": 388,
            "totalTokens": 2692
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "89c02746-6b7c-4bb5-957e-f0961e20494c",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:12:46 GMT",
                "content-type": "application/json",
                "content-length": "2031",
                "connection": "keep-alive",
                "x-amzn-requestid": "89c02746-6b7c-4bb5-957e-f0961e20494c"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow down the broad terms to more specific ones as per the Target Schema provided.\n\n1. **Diagnosis**: The input is \"Neurofibromatosis\". The Target Schema provides several specific types related to Neurofibromatosis, such as \"Neurofibromatosis type 1\". Since \"Neurofibromatosis\" is most commonly associated with \"Neurofibromatosis type 1\" and it's the most specific term available in the schema related to Neurofibromatosis, we will use \"Neurofibromatosis type 1\".\n\n2. **Assay**: The input is \"DNA sequencing\". The Target Schema lists various sequencing and genetic analysis techniques. \"DNA sequencing\" is a broad term that can be narrowed down to more specific techniques. The closest and most appropriate term from the schema is \"Sanger sequencing\" or other next-generation sequencing techniques like \"whole exome sequencing\" or \"whole genome sequencing\". However, without more specific information on the type of DNA sequencing, we'll choose \"Sanger sequencing\" as it's a specific and commonly used method.\n\n3. **TumorType**: The input is \"Neurofibroma\". The Target Schema provides several specific types of Neurofibroma. \"Neurofibroma\" is a broad term that can be specified into types like \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", etc. Since the exact type of Neurofibroma isn't specified, we'll choose \"Neurofibroma\" as it is listed in the schema, assuming it's about the general category.\n\nCorrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"Sanger sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction adheres to the Target Schema's controlled terminology, ensuring that the values used are exact and specific."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2304,
              "outputTokens": 388,
              "totalTokens": 2692
            },
            "metrics": {
              "latencyMs": 2414
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2304,
          "output_tokens": 388,
          "total_tokens": 2692
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"NF\". The Target Schema provides several diagnosis related to Neurofibromatosis, such as \"Neurofibromatosis type 1\". Since \"NF\" is often used to refer to Neurofibromatosis type 1, we can narrow it down to \"Neurofibromatosis type 1\".\n\n2. For the \"assay\" field, the input is \"exome sequencing\". The Target Schema has an enum value \"whole exome sequencing\" which matches the context of \"exome sequencing\". Therefore, we can replace \"exome sequencing\" with \"whole exome sequencing\".\n\n3. For the \"tumorType\" field, the input is \"sarcoma\". The Target Schema has \"Sarcoma\" as an enum value, which is a direct match. Therefore, no change is needed for \"tumorType\".\n\nHere is the corrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\nThis corrected metadata adheres to the controlled terminology specified in the Target Schema.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2301,
            "outputTokens": 268,
            "totalTokens": 2569
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "af8682c1-efd7-4333-aecd-46ca596e3f4b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:12:48 GMT",
                "content-type": "application/json",
                "content-length": "1362",
                "connection": "keep-alive",
                "x-amzn-requestid": "af8682c1-efd7-4333-aecd-46ca596e3f4b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"NF\". The Target Schema provides several diagnosis related to Neurofibromatosis, such as \"Neurofibromatosis type 1\". Since \"NF\" is often used to refer to Neurofibromatosis type 1, we can narrow it down to \"Neurofibromatosis type 1\".\n\n2. For the \"assay\" field, the input is \"exome sequencing\". The Target Schema has an enum value \"whole exome sequencing\" which matches the context of \"exome sequencing\". Therefore, we can replace \"exome sequencing\" with \"whole exome sequencing\".\n\n3. For the \"tumorType\" field, the input is \"sarcoma\". The Target Schema has \"Sarcoma\" as an enum value, which is a direct match. Therefore, no change is needed for \"tumorType\".\n\nHere is the corrected metadata in JSON format:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```\n\nThis corrected metadata adheres to the controlled terminology specified in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2301,
              "outputTokens": 268,
              "totalTokens": 2569
            },
            "metrics": {
              "latencyMs": 1522
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2301,
          "output_tokens": 268,
          "total_tokens": 2569
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"Neurofibromatoses\". Looking at the Target Schema for \"diagnosis\", the closest and most specific term related to \"Neurofibromatoses\" is \"Neurofibromatosis type 1\". Although \"Neurofibromatoses\" can refer to a group of disorders including Neurofibromatosis type 1, type 2, and Schwannomatosis, \"Neurofibromatosis type 1\" is a specific condition within this group. If more specific information is not available, this is the most appropriate choice.\n\n2. **Assay**: The input value is \"assay by high throughput sequencer\". The Target Schema for \"assay\" includes several sequencing-related terms. \"whole genome sequencing\", \"whole exome sequencing\", and \"next generation targeted sequencing\" are all possibilities for \"assay by high throughput sequencer\". Since \"next generation targeted sequencing\" is listed in the enum and is a broad category that encompasses various high-throughput sequencing techniques, it is a suitable choice.\n\n3. **TumorType**: The input value is \"Nerve Sheath Neoplasm\". The Target Schema for \"tumorType\" includes \"Neurofibroma\", \"Schwannoma\", and \"Malignant Peripheral Nerve Sheath Tumor\", all of which are types of nerve sheath neoplasms. \"Neurofibroma\" is a specific type of nerve sheath tumor, making it a more precise term.\n\nCorrected metadata in JSON format, using the exact controlled terminology from the Target Schema:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"next generation targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction narrows down the broad input terms to more specific values that are present in the Target Schema, thus providing more precise metadata.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2313,
            "outputTokens": 405,
            "totalTokens": 2718
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "a3d4b8c7-faed-4834-bf55-ad106609c3df",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:12:50 GMT",
                "content-type": "application/json",
                "content-length": "2081",
                "connection": "keep-alive",
                "x-amzn-requestid": "a3d4b8c7-faed-4834-bf55-ad106609c3df"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"Neurofibromatoses\". Looking at the Target Schema for \"diagnosis\", the closest and most specific term related to \"Neurofibromatoses\" is \"Neurofibromatosis type 1\". Although \"Neurofibromatoses\" can refer to a group of disorders including Neurofibromatosis type 1, type 2, and Schwannomatosis, \"Neurofibromatosis type 1\" is a specific condition within this group. If more specific information is not available, this is the most appropriate choice.\n\n2. **Assay**: The input value is \"assay by high throughput sequencer\". The Target Schema for \"assay\" includes several sequencing-related terms. \"whole genome sequencing\", \"whole exome sequencing\", and \"next generation targeted sequencing\" are all possibilities for \"assay by high throughput sequencer\". Since \"next generation targeted sequencing\" is listed in the enum and is a broad category that encompasses various high-throughput sequencing techniques, it is a suitable choice.\n\n3. **TumorType**: The input value is \"Nerve Sheath Neoplasm\". The Target Schema for \"tumorType\" includes \"Neurofibroma\", \"Schwannoma\", and \"Malignant Peripheral Nerve Sheath Tumor\", all of which are types of nerve sheath neoplasms. \"Neurofibroma\" is a specific type of nerve sheath tumor, making it a more precise term.\n\nCorrected metadata in JSON format, using the exact controlled terminology from the Target Schema:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"next generation targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction narrows down the broad input terms to more specific values that are present in the Target Schema, thus providing more precise metadata."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2313,
              "outputTokens": 405,
              "totalTokens": 2718
            },
            "metrics": {
              "latencyMs": 2296
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2313,
          "output_tokens": 405,
          "total_tokens": 2718
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow down the broad terms to more specific ones as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"neurocutaneous syndrome\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, \"Neurofibromatosis type 1\" is a specific type of neurocutaneous syndrome. Since \"neurocutaneous syndrome\" could refer to several conditions including Neurofibromatosis type 1, and given that it's the closest specific condition related to the context of other fields like \"tumorType\" and the schema provided, we can consider it. However, without more context, the most accurate choice isn't directly clear. \"Neurofibromatosis type 1\" is a plausible narrowing.\n\n2. **Assay**: The term \"spectroscopy\" is broad and has several specific types listed in the Target Schema. \"FTIR spectroscopy\" is a specific type of spectroscopy, making it a suitable narrowed choice.\n\n3. **TumorType**: The value \"unknown\" is already specific in the context that it directly matches one of the enum values in the Target Schema for \"tumorType\". Therefore, no change is needed here.\n\nGiven these considerations, the corrected metadata in JSON format would be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\nThis correction adheres to the Target Schema's controlled terminology, ensuring that the values used are exact matches to the enum values specified.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2302,
            "outputTokens": 325,
            "totalTokens": 2627
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "ff42b047-7aa0-4bd1-bf88-348cb183e940",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:12:52 GMT",
                "content-type": "application/json",
                "content-length": "1750",
                "connection": "keep-alive",
                "x-amzn-requestid": "ff42b047-7aa0-4bd1-bf88-348cb183e940"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow down the broad terms to more specific ones as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"neurocutaneous syndrome\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, \"Neurofibromatosis type 1\" is a specific type of neurocutaneous syndrome. Since \"neurocutaneous syndrome\" could refer to several conditions including Neurofibromatosis type 1, and given that it's the closest specific condition related to the context of other fields like \"tumorType\" and the schema provided, we can consider it. However, without more context, the most accurate choice isn't directly clear. \"Neurofibromatosis type 1\" is a plausible narrowing.\n\n2. **Assay**: The term \"spectroscopy\" is broad and has several specific types listed in the Target Schema. \"FTIR spectroscopy\" is a specific type of spectroscopy, making it a suitable narrowed choice.\n\n3. **TumorType**: The value \"unknown\" is already specific in the context that it directly matches one of the enum values in the Target Schema for \"tumorType\". Therefore, no change is needed here.\n\nGiven these considerations, the corrected metadata in JSON format would be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\nThis correction adheres to the Target Schema's controlled terminology, ensuring that the values used are exact matches to the enum values specified."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2302,
              "outputTokens": 325,
              "totalTokens": 2627
            },
            "metrics": {
              "latencyMs": 2366
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2302,
          "output_tokens": 325,
          "total_tokens": 2627
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to examine each field and replace broad synonyms with more specific, precise terms as per the Target Schema provided.\n\n1. **Diagnosis**: The value is \"Not Applicable\". This is an exact match in the controlled terminology for \"diagnosis\", so no correction is needed.\n\n2. **Assay**: The value is \"immunoassay\". Upon reviewing the Target Schema for \"assay\", we find that \"immunoassay\" is listed as one of the enum values. Therefore, \"immunoassay\" is already a precise term according to the schema, and no correction is required.\n\n3. **TumorType**: The value is \"neurofibroma\". Looking at the enum values for \"tumorType\" in the Target Schema, we see that \"Neurofibroma\" is listed. The input value \"neurofibroma\" matches \"Neurofibroma\" when case sensitivity is ignored, which is appropriate here since the enum values are case-sensitive but the match is exact when ignoring case. Thus, the correct value should be \"Neurofibroma\" to match the schema exactly.\n\nCorrected metadata in JSON format with the same structure as the input:\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction ensures that the metadata values are precise and match the controlled terminology provided in the Target Schema.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2304,
            "outputTokens": 296,
            "totalTokens": 2600
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "517316e8-db26-4b89-9323-64ee723f1fd0",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:12:54 GMT",
                "content-type": "application/json",
                "content-length": "1562",
                "connection": "keep-alive",
                "x-amzn-requestid": "517316e8-db26-4b89-9323-64ee723f1fd0"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to examine each field and replace broad synonyms with more specific, precise terms as per the Target Schema provided.\n\n1. **Diagnosis**: The value is \"Not Applicable\". This is an exact match in the controlled terminology for \"diagnosis\", so no correction is needed.\n\n2. **Assay**: The value is \"immunoassay\". Upon reviewing the Target Schema for \"assay\", we find that \"immunoassay\" is listed as one of the enum values. Therefore, \"immunoassay\" is already a precise term according to the schema, and no correction is required.\n\n3. **TumorType**: The value is \"neurofibroma\". Looking at the enum values for \"tumorType\" in the Target Schema, we see that \"Neurofibroma\" is listed. The input value \"neurofibroma\" matches \"Neurofibroma\" when case sensitivity is ignored, which is appropriate here since the enum values are case-sensitive but the match is exact when ignoring case. Thus, the correct value should be \"Neurofibroma\" to match the schema exactly.\n\nCorrected metadata in JSON format with the same structure as the input:\n\n```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction ensures that the metadata values are precise and match the controlled terminology provided in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2304,
              "outputTokens": 296,
              "totalTokens": 2600
            },
            "metrics": {
              "latencyMs": 1749
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2304,
          "output_tokens": 296,
          "total_tokens": 2600
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"neurofibromatosis\". The Target Schema provides several specific types of neurofibromatosis or related conditions. The most specific match for \"neurofibromatosis\" in the schema is \"Neurofibromatosis type 1\". Therefore, we will replace \"neurofibromatosis\" with \"Neurofibromatosis type 1\".\n\n2. For the \"assay\" field, the input is \"plate based reporter assay\". The Target Schema does not have an exact match for \"plate based reporter assay\", but it does have \"massively parallel reporter assay\". Since \"plate based reporter assay\" can be considered a type of reporter assay and given the available options, we will look for a closer match. However, there's no direct \"plate based reporter assay\" in the enum. The closest related term is not directly available, so we need to check if there's any other related term that could fit. Upon closer inspection, there isn't a direct match, but \"massively parallel reporter assay\" is a specific type of reporter assay. Without a more specific match, we might consider this or look for other assay types that could be related. Yet, we must stick to the exact values provided.\n\n3. For the \"tumorType\" field, the input is \"benign neurofibroma\". The Target Schema has several types of neurofibroma. \"Neurofibroma\" is a direct match, and it's more specific than \"benign neurofibroma\". There are more specific types like \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", etc. Since \"benign neurofibroma\" is not directly listed but \"Neurofibroma\" is, and given that neurofibromas are typically benign, we can use \"Neurofibroma\" as the corrected value.\n\nGiven these considerations, the corrected metadata will be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\", \n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nHowever, it's worth noting that \"plate based reporter assay\" is not directly available in the enum for \"assay\". If the exact term is not available, it might be necessary to either choose a more general category if available or leave it as is if no suitable match is found. For the sake of this task, we'll proceed with the available information and closest matches.\n\nTo be more accurate in the \"assay\" field, since \"plate based reporter assay\" is not an exact match and \"massively parallel reporter assay\" is the closest related term available in the schema, the final corrected JSON will be based on available enum values.\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2309,
            "outputTokens": 627,
            "totalTokens": 2936
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "172a4f6d-ff63-4c46-abce-32adcb82c4ed",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:12:58 GMT",
                "content-type": "application/json",
                "content-length": "3063",
                "connection": "keep-alive",
                "x-amzn-requestid": "172a4f6d-ff63-4c46-abce-32adcb82c4ed"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"neurofibromatosis\". The Target Schema provides several specific types of neurofibromatosis or related conditions. The most specific match for \"neurofibromatosis\" in the schema is \"Neurofibromatosis type 1\". Therefore, we will replace \"neurofibromatosis\" with \"Neurofibromatosis type 1\".\n\n2. For the \"assay\" field, the input is \"plate based reporter assay\". The Target Schema does not have an exact match for \"plate based reporter assay\", but it does have \"massively parallel reporter assay\". Since \"plate based reporter assay\" can be considered a type of reporter assay and given the available options, we will look for a closer match. However, there's no direct \"plate based reporter assay\" in the enum. The closest related term is not directly available, so we need to check if there's any other related term that could fit. Upon closer inspection, there isn't a direct match, but \"massively parallel reporter assay\" is a specific type of reporter assay. Without a more specific match, we might consider this or look for other assay types that could be related. Yet, we must stick to the exact values provided.\n\n3. For the \"tumorType\" field, the input is \"benign neurofibroma\". The Target Schema has several types of neurofibroma. \"Neurofibroma\" is a direct match, and it's more specific than \"benign neurofibroma\". There are more specific types like \"Cutaneous Neurofibroma\", \"Localized Neurofibroma\", \"Plexiform Neurofibroma\", etc. Since \"benign neurofibroma\" is not directly listed but \"Neurofibroma\" is, and given that neurofibromas are typically benign, we can use \"Neurofibroma\" as the corrected value.\n\nGiven these considerations, the corrected metadata will be:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\", \n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nHowever, it's worth noting that \"plate based reporter assay\" is not directly available in the enum for \"assay\". If the exact term is not available, it might be necessary to either choose a more general category if available or leave it as is if no suitable match is found. For the sake of this task, we'll proceed with the available information and closest matches.\n\nTo be more accurate in the \"assay\" field, since \"plate based reporter assay\" is not an exact match and \"massively parallel reporter assay\" is the closest related term available in the schema, the final corrected JSON will be based on available enum values.\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2309,
              "outputTokens": 627,
              "totalTokens": 2936
            },
            "metrics": {
              "latencyMs": 3721
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2309,
          "output_tokens": 627,
          "total_tokens": 2936
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"RASopathy\". RASopathies are a group of genetic disorders caused by mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway. Noonan Syndrome is a specific RASopathy. Since \"RASopathy\" is not directly listed in the enum for \"diagnosis\", we should look for the most specific condition it could refer to. \"Noonan Syndrome\" is a specific type of RASopathy and is listed in the enum.\n\n2. **Assay**: The input value is \"immunoassay\". This term is broad and encompasses several specific types of assays. The Target Schema includes several specific types of immunoassays indirectly (e.g., \"ELISA\" is a type of immunoassay). However, \"immunoassay\" is directly listed in the enum for \"assay\", so it is already specific enough according to the provided schema.\n\n3. **TumorType**: The input value is \"NFIB\". This is not directly listed in the enum for \"tumorType\". However, \"Neurofibroma\" is a plausible related term, and it is listed. More specifically, there are various types of neurofibromas (e.g., \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\") listed. Without more context, \"Neurofibroma\" is the most appropriate choice as it is related to NF1, and \"NFIB\" could be interpreted as related to Neurofibroma.\n\nGiven these considerations, the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction narrows the broad terms to more specific ones where possible, using the exact values from the Target Schema.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2302,
            "outputTokens": 399,
            "totalTokens": 2701
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "163e7381-35b9-4ea9-b4d9-f8f3f155c2f5",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:13:01 GMT",
                "content-type": "application/json",
                "content-length": "1989",
                "connection": "keep-alive",
                "x-amzn-requestid": "163e7381-35b9-4ea9-b4d9-f8f3f155c2f5"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The input value is \"RASopathy\". RASopathies are a group of genetic disorders caused by mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway. Noonan Syndrome is a specific RASopathy. Since \"RASopathy\" is not directly listed in the enum for \"diagnosis\", we should look for the most specific condition it could refer to. \"Noonan Syndrome\" is a specific type of RASopathy and is listed in the enum.\n\n2. **Assay**: The input value is \"immunoassay\". This term is broad and encompasses several specific types of assays. The Target Schema includes several specific types of immunoassays indirectly (e.g., \"ELISA\" is a type of immunoassay). However, \"immunoassay\" is directly listed in the enum for \"assay\", so it is already specific enough according to the provided schema.\n\n3. **TumorType**: The input value is \"NFIB\". This is not directly listed in the enum for \"tumorType\". However, \"Neurofibroma\" is a plausible related term, and it is listed. More specifically, there are various types of neurofibromas (e.g., \"Cutaneous Neurofibroma\", \"Plexiform Neurofibroma\") listed. Without more context, \"Neurofibroma\" is the most appropriate choice as it is related to NF1, and \"NFIB\" could be interpreted as related to Neurofibroma.\n\nGiven these considerations, the corrected metadata would be:\n\n```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\nThis correction narrows the broad terms to more specific ones where possible, using the exact values from the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2302,
              "outputTokens": 399,
              "totalTokens": 2701
            },
            "metrics": {
              "latencyMs": 2908
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2302,
          "output_tokens": 399,
          "total_tokens": 2701
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to narrow down the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"NF\". \"NF\" is commonly known to stand for Neurofibromatosis. The Target Schema provides \"Neurofibromatosis type 1\" as a specific term under the \"diagnosis\" enum. Given that \"NF\" could refer to Neurofibromatosis type 1 or type 2, and since \"Neurofibromatosis type 1\" is listed in the enum, we will use \"Neurofibromatosis type 1\" as the corrected value, assuming the context is NF1. However, it's worth noting that without more specific information, it could also potentially refer to NF2, but \"Neurofibromatosis type 1\" is a reasonable choice given the available options.\n\n2. For the \"assay\" field, the input is \"medical imaging\". The Target Schema lists various specific types of medical imaging under the \"assay\" enum, such as \"conventional MRI\", \"diffusion MRI\", \"functional MRI\", \"high frequency ultrasound\", etc. Since \"medical imaging\" is a broad term and the exact type of imaging is not specified, we need to choose a more specific term from the enum. One of the most general and commonly used medical imaging techniques listed is \"conventional MRI\". Therefore, we will correct \"medical imaging\" to \"conventional MRI\" for the sake of specificity, although the actual correction could vary based on the specific type of medical imaging intended.\n\n3. For the \"tumorType\" field, the input is \"unknown\". The Target Schema includes \"Unknown\" as a valid enum value under \"tumorType\". Therefore, \"unknown\" can be directly mapped to \"Unknown\".\n\nThe corrected metadata in JSON format, using the same structure as the input, is as follows:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\nThis correction adheres to the Target Schema's controlled terminology, ensuring that the values used are exact matches from the provided enums.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2299,
            "outputTokens": 453,
            "totalTokens": 2752
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "3f9147fe-0555-45ce-ac24-efc0c1c050b6",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:13:04 GMT",
                "content-type": "application/json",
                "content-length": "2262",
                "connection": "keep-alive",
                "x-amzn-requestid": "3f9147fe-0555-45ce-ac24-efc0c1c050b6"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to narrow down the broad synonyms to more specific terms as per the Target Schema provided.\n\n1. For the \"diagnosis\" field, the input is \"NF\". \"NF\" is commonly known to stand for Neurofibromatosis. The Target Schema provides \"Neurofibromatosis type 1\" as a specific term under the \"diagnosis\" enum. Given that \"NF\" could refer to Neurofibromatosis type 1 or type 2, and since \"Neurofibromatosis type 1\" is listed in the enum, we will use \"Neurofibromatosis type 1\" as the corrected value, assuming the context is NF1. However, it's worth noting that without more specific information, it could also potentially refer to NF2, but \"Neurofibromatosis type 1\" is a reasonable choice given the available options.\n\n2. For the \"assay\" field, the input is \"medical imaging\". The Target Schema lists various specific types of medical imaging under the \"assay\" enum, such as \"conventional MRI\", \"diffusion MRI\", \"functional MRI\", \"high frequency ultrasound\", etc. Since \"medical imaging\" is a broad term and the exact type of imaging is not specified, we need to choose a more specific term from the enum. One of the most general and commonly used medical imaging techniques listed is \"conventional MRI\". Therefore, we will correct \"medical imaging\" to \"conventional MRI\" for the sake of specificity, although the actual correction could vary based on the specific type of medical imaging intended.\n\n3. For the \"tumorType\" field, the input is \"unknown\". The Target Schema includes \"Unknown\" as a valid enum value under \"tumorType\". Therefore, \"unknown\" can be directly mapped to \"Unknown\".\n\nThe corrected metadata in JSON format, using the same structure as the input, is as follows:\n\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\nThis correction adheres to the Target Schema's controlled terminology, ensuring that the values used are exact matches from the provided enums."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2299,
              "outputTokens": 453,
              "totalTokens": 2752
            },
            "metrics": {
              "latencyMs": 3188
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2299,
          "output_tokens": 453,
          "total_tokens": 2752
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad or non-specific terms with more precise terms as defined in the Target Schema.\n\n1. **Diagnosis**: The term \"neurocristopathy\" is broad and encompasses a range of conditions related to the abnormal development of cells derived from the neural crest. Looking at the provided enum values for \"diagnosis\", the closest and most specific term related to neural crest derivatives and relevant to the context would be \"Neurofibromatosis type 1\", as neurofibromas are derived from neural crest cells. However, \"neurocristopathy\" is not directly listed, and its direct mapping isn't straightforward without more context. Given the options, if the condition is related to NF1, it could be a suitable choice. Otherwise, \"Schwannomatosis\" or other specific conditions could be considered if more context is available. For the sake of this task, let's assume it's not directly mappable to the given enums without more specific information, so we'll consider \"Unknown\" as a potential fallback if a more specific diagnosis isn't available.\n\n2. **Assay**: The term \"transcriptomics\" is a broad field that encompasses several specific techniques for studying the transcriptome. The Target Schema includes \"RNA-seq\", \"lncRNA-seq\", \"miRNA-seq\", \"single-cell RNA-seq\", and \"whole transcriptome sequencing\" as specific transcriptomics-related assays. \"RNA-seq\" is a common and specific technique used in transcriptomics, making it a suitable choice for narrowing down \"transcriptomics\".\n\n3. **TumorType**: \"Neurolemmoma\" is an older term for \"Schwannoma\", which is a type of tumor that arises from Schwann cells. The enum values for \"tumorType\" include \"Schwannoma\", making it a direct and appropriate match for \"neurolemmoma\".\n\nTherefore, the corrected metadata, using the exact controlled terminology from the Target Schema, would be:\n\n```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction assumes that \"neurocristopathy\" is not directly mappable to the provided diagnosis enums without more context, and thus defaults to \"Unknown\". If more specific information about the diagnosis were available, a more precise term could be used. \"Transcriptomics\" is narrowed down to \"RNA-seq\", a specific and commonly used transcriptomics assay. \"Neurolemmoma\" is correctly identified as \"Schwannoma\".",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2308,
            "outputTokens": 518,
            "totalTokens": 2826
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "af58d8ca-f741-4ad4-9e57-16456d6fc1b3",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:13:08 GMT",
                "content-type": "application/json",
                "content-length": "2672",
                "connection": "keep-alive",
                "x-amzn-requestid": "af58d8ca-f741-4ad4-9e57-16456d6fc1b3"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad or non-specific terms with more precise terms as defined in the Target Schema.\n\n1. **Diagnosis**: The term \"neurocristopathy\" is broad and encompasses a range of conditions related to the abnormal development of cells derived from the neural crest. Looking at the provided enum values for \"diagnosis\", the closest and most specific term related to neural crest derivatives and relevant to the context would be \"Neurofibromatosis type 1\", as neurofibromas are derived from neural crest cells. However, \"neurocristopathy\" is not directly listed, and its direct mapping isn't straightforward without more context. Given the options, if the condition is related to NF1, it could be a suitable choice. Otherwise, \"Schwannomatosis\" or other specific conditions could be considered if more context is available. For the sake of this task, let's assume it's not directly mappable to the given enums without more specific information, so we'll consider \"Unknown\" as a potential fallback if a more specific diagnosis isn't available.\n\n2. **Assay**: The term \"transcriptomics\" is a broad field that encompasses several specific techniques for studying the transcriptome. The Target Schema includes \"RNA-seq\", \"lncRNA-seq\", \"miRNA-seq\", \"single-cell RNA-seq\", and \"whole transcriptome sequencing\" as specific transcriptomics-related assays. \"RNA-seq\" is a common and specific technique used in transcriptomics, making it a suitable choice for narrowing down \"transcriptomics\".\n\n3. **TumorType**: \"Neurolemmoma\" is an older term for \"Schwannoma\", which is a type of tumor that arises from Schwann cells. The enum values for \"tumorType\" include \"Schwannoma\", making it a direct and appropriate match for \"neurolemmoma\".\n\nTherefore, the corrected metadata, using the exact controlled terminology from the Target Schema, would be:\n\n```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction assumes that \"neurocristopathy\" is not directly mappable to the provided diagnosis enums without more context, and thus defaults to \"Unknown\". If more specific information about the diagnosis were available, a more precise term could be used. \"Transcriptomics\" is narrowed down to \"RNA-seq\", a specific and commonly used transcriptomics assay. \"Neurolemmoma\" is correctly identified as \"Schwannoma\"."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2308,
              "outputTokens": 518,
              "totalTokens": 2826
            },
            "metrics": {
              "latencyMs": 3613
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2308,
          "output_tokens": 518,
          "total_tokens": 2826
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"phakomatosis\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, we can see that \"Neurofibromatosis type 1\" is a specific condition that falls under the broader category of phakomatoses. However, \"phakomatosis\" can refer to several neurocutaneous syndromes, including but not limited to Neurofibromatosis type 1. Since \"Schwannomatosis\" is also a type of phakomatosis and is listed in the enum, we need to determine the most appropriate specific diagnosis. Without more context, \"Schwannomatosis-NOS\" (Not Otherwise Specified) could be a reasonable choice if the specific type of schwannomatosis is not known. However, \"Neurofibromatosis type 1\" is a more commonly referenced phakomatosis. Let's choose \"Schwannomatosis-NOS\" for this example.\n\n2. **Assay**: The term \"viability assay\" is broad. The Target Schema provides several specific types of viability assays under \"assay\". \"cell viability assay\" is a direct match and is listed in the enum.\n\n3. **TumorType**: \"tumor of cranial and spinal nerves\" is a broad term. The enum for \"tumorType\" includes \"Schwannoma\", which is a type of tumor that can occur on cranial and spinal nerves. This is a more specific term that fits the given description.\n\nTherefore, the corrected metadata, using the exact controlled terminology from the Target Schema, is as follows:\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction ensures that the metadata uses the precise terminology defined in the Target Schema, enhancing specificity and consistency.",
          "model_id": "us.meta.llama4-maverick-17b-instruct-v1:0",
          "usage": {
            "inputTokens": 2309,
            "outputTokens": 408,
            "totalTokens": 2717
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "303a2dea-2d03-4788-af47-b57cc1d6083e",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Sat, 15 Nov 2025 04:13:10 GMT",
                "content-type": "application/json",
                "content-length": "2056",
                "connection": "keep-alive",
                "x-amzn-requestid": "303a2dea-2d03-4788-af47-b57cc1d6083e"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "To correct the given metadata, we need to replace the broad synonyms with more specific terms as per the Target Schema provided.\n\n1. **Diagnosis**: The term \"phakomatosis\" is broad and encompasses several conditions. Looking at the enum values for \"diagnosis\" in the Target Schema, we can see that \"Neurofibromatosis type 1\" is a specific condition that falls under the broader category of phakomatoses. However, \"phakomatosis\" can refer to several neurocutaneous syndromes, including but not limited to Neurofibromatosis type 1. Since \"Schwannomatosis\" is also a type of phakomatosis and is listed in the enum, we need to determine the most appropriate specific diagnosis. Without more context, \"Schwannomatosis-NOS\" (Not Otherwise Specified) could be a reasonable choice if the specific type of schwannomatosis is not known. However, \"Neurofibromatosis type 1\" is a more commonly referenced phakomatosis. Let's choose \"Schwannomatosis-NOS\" for this example.\n\n2. **Assay**: The term \"viability assay\" is broad. The Target Schema provides several specific types of viability assays under \"assay\". \"cell viability assay\" is a direct match and is listed in the enum.\n\n3. **TumorType**: \"tumor of cranial and spinal nerves\" is a broad term. The enum for \"tumorType\" includes \"Schwannoma\", which is a type of tumor that can occur on cranial and spinal nerves. This is a more specific term that fits the given description.\n\nTherefore, the corrected metadata, using the exact controlled terminology from the Target Schema, is as follows:\n\n```json\n{\n  \"diagnosis\": \"Schwannomatosis-NOS\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\nThis correction ensures that the metadata uses the precise terminology defined in the Target Schema, enhancing specificity and consistency."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2309,
              "outputTokens": 408,
              "totalTokens": 2717
            },
            "metrics": {
              "latencyMs": 2403
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2309,
          "output_tokens": 408,
          "total_tokens": 2717
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.3666666666666667,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 26.475952863693237,
    "token_usage": {
      "input_tokens": 23051,
      "output_tokens": 4087,
      "total_tokens": 27138
    }
  }
}